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ABSTRACT  
Objective: The aim of this research paper was to develop a simple, sensitive, rapid, accurate and economical Ultra Violet spectrophotometric 
method for the Analysis of Acetylcholinesterase Inhibitor.  
Methods: The study was performed in pH 7.4 phosphate buffer and presence of the drug was analysed using UV spectrophotometer. Various 
analytical parameters such as linearity, range, precision, accuracy, limit of detection (LOD) and limit of quantification (LOQ) were determined 
according International Conference on Harmonization (ICH) guidelines. 
Results: Absorbance maximum (ʎmax) of drug in pH 7.4 phosphate buffer were found to be 270.5 nm. Beer’s law was obeyed over the 
concentration range of 2 - 20 mg/ml with a correlation coefficient (R2
Conclusion: The results of the study demonstrated that the developed method is accurate, precise and reproducible while being simple, cheap and 
less time consuming and hence can be suitably applied for the analysis of donepezil in pharmaceutical preparations.  
) value of 0.999. % RSD values below 2 at different concentration levels for 
Intra and inter-day precision indicated that the proposed spectrophotometric method is highly reproducible. LOD and LOQ were 0.401 and 1.22 
µg/ml respectively signifying that it can be adopted for routine quality testing.  
Keywords: Acetylcholinesterase inhibitor, Donepezil, Quantitative determination, UV spectrophotometric method. 
 
INTRODUCTION  
In this study, the donepezil was selected as Acetylcholinesterase 
Inhibitor. Donepezil occurs as a white crystalline powder and 
chemically known as 2-[(1-benzyl-4-piperidyl) methyl]-5,6-
dimethoxy-2,3-dihydroinden-1-one with molecular weight of 
379.492 g mol-1
A consistent pathological change in Alzheimer’s disease is the 
degeneration of cholinergic neuronal pathways that project from the 
basal forebrain to the cerebral cortex and hippocampus. The 
resulting hypofunction of the cholinergic systems is thought to 
account for some of the clinical manifestations of dementia [5]. 
Donepezil is postulated to exert its therapeutic effect by enhancing 
cholinergic function and acetylcholine levels of the brain. This is 
accomplished by increasing the concentration of acetylcholine 
through reversible inhibition of its hydrolysis by acetyl 
cholinesterase [6]. The recommended initial dose of donepezil is 5 
mg taken once daily [7]. A 50% inhibition of acetylcholinesterase 
activity is obtained at a plasma drug concentration of 15.6 ng/ml, 
and the inhibition plateaus at the plasma concentration of donepezil 
higher than 50 ng/ml [8].  
 (Fig. 1) [1]. It is a piperidine-based, reversible and 
non-competitive inhibitor of the enzyme acetylcholinesterase [2]. It 
produces obvious and long-lasting inhibition of brain cholinesterase 
without marked effects on cholinesterase in peripheral tissues and 
increases the brain content of acetylcholine in vivo [3]. It is the 
second drug approved by the FDA for the treatment of mild to 
moderate dementia of the Alzheimer’s type. Alzheimer disease is a 
neurodegenerative disorder characterized by progressive loss of 
memory followed by complete dementia [4].  
 
Fig. 1: Structure of donepezil 
Several analytical techniques have been used for the analysis of 
donepezil in pharmaceutical preparation. These include high 
performance liquid chromatography (HPLC) [9-11] fluorescence 
(FL) [12] or mass spectrometric (MS) detector [13], solvent 
extraction spectrophotometry [14], spectrofluorimetry [15] and 
colorimeter [16] etc. In the luminosity and fact of above literature a 
simple UV spectrophotometric method for the analysis of donepezil 
has been developed. The proposed method offers several advantages 
over HPLC methods which are very sensitive but need sophisticated 
instrumentation & expert hands [9-13] and extraction procedure 
always not quantitative [14].  
The present procedure neither requires any extraction nor any 
elaborate equipment and the method is less time consuming.  So, the 
aim of this research work was to develop a UV spectrophotometric 
method for the determination of donepezil in pharmaceutical 
preparations. UV spectrophotometry is still popular because of the 
inherent simplicity, low cost, sensitivity, speed and reliability for 
determination of drugs in pharmaceutical preparations.  
The different analytical performance parameters such as linearity, 
precision, accuracy, limit of detection (LOD) and limit of 
quantification (LOQ) were determined according to ICH Q2 (R1) 
guidelines [17]. 
MATERIALS AND METHODS 
Instruments  
A Shimadzu UV visible spectrophotometer (UV -1800, Shimadzu 
Corporation, Kyoto, Japan) was used for all absorbance 
measurements with one cm matched quartz cells and Shimadzu 
electronic balance (AUX 220, Shimadzu Corporation, Kyoto, Japan) 
was used for weighing the sample. 
Materials 
Donepezil was received as a gift sample from Jubilant Life Sciences 
Ltd. Noida, UP (India), Potassium dihydrogen phosphate was 
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purchased from Qualigens fine chemicals, Mumbai (India), and 
Sodium hydroxide was purchased from Fisher scientific, Mumbai 
(India). All chemicals and reagents used were of analytical grade. Double 
distilled water was used to prepare solutions wherever required and it 
was filtered before use through a 0.22 µm membrane filter.  
Methods 
Preparation of phosphate buffer pH 7.4 
The phosphate buffer pH 7.4 was prepared as per specifications 
given in Indian Pharmacopoeia [18]. 
Preparation of 0.2 M potassium dihydrogen phosphate solution 
27.218 gm of potassium dihydrogen phosphate was dissolved in 
1000 ml of distilled water to produce 0.2M solution of potassium 
dihydrogen phosphate. 
Preparation of 0.2 M NaOH solution 
8 gm of sodium hydroxide was dissolved in 1000 ml of distilled 
water to produce 0.2M sodium hydroxide solution 
Preparation of buffer 
50 ml of 0.2 M potassium dihydrogen phosphate was placed in 200 
ml of volumetric flask, and then pH was adjusted to 7.4 0 ± 0.05 by 
adding 39.1 ml of 0.2 M NaOH solution. Finally, the volume was 
made upto 200 ml with distilled water, and then filtered through 
0.22 μm membrane filter. 
Determination of wavelength of maximum absorption and 
preparation of calibration curve 
A standard stock solution of drug sample (100 μg/ml) was prepared 
by dissolving 10 mg of the drug in small quantity methanol in a 100 
ml of volumetric flask and then volume was made upto mark with 
phosphate buffer (pH 7.4). The dilutions of this stock solution were 
made by diluting the required aliquot with phosphate buffer to 
obtain solutions in the range of 2- 20 μg/ml. An UV spectroscopic 
scanning (200– 400 nm) was carried out with drug solutions to 
determine the absorbance and maximum absorption (ʎ max) using 
phosphate buffer (pH 7.4) as blank. 
Validation Procedure  
Method was validated according to International Conference on 
Harmonization (ICH) guidelines [17] in terms of linearity, range, 
accuracy, precision, limit of detection (LOD), and limit of 
quantitation (LOQ). 
Linearity and range 
Linearity is the ability of the method to obtain test results that are 
directly proportional to analyte concentration within a given range. 
The range of an analytical method is the interval between the upper 
and lower concentration of analyte for which it has been 
demonstrated that the analytical procedure has a suitable level of 
precision, accuracy and linearity.  
To study the linearity, serial dilutions of donepezil were suitably 
prepared in the concentration range of 2 - 20 μg/ ml 
Repeatability of drug sample was determined as intraday variation 
(3 concentrations/3 replicates each, three times a day / a minimum 
of 9 determinations covering the specified range for the procedure) 
whereas intermediate precision was determined by interday 
variation (for three different days) for the determination of 
donepezil at three different concentration levels of 6, 12 and 18 
μg/ml in triplicate. The % RSD was calculated for absorbance to 
obtain the intraday variation and interday variation. 
Accuracy as recovery studies 
Accuracy is the closeness of the test results obtained by the 
analytical method to the true value. The method was further 
validated to check the sensitivity of the method to determine 
donepezil in the presence of excipients. The accuracy of the method 
was evaluated by standard addition method. Pre-analysed samples 
of donepezil (8 μg /ml) were spiked with the extra 50%, 100% and 
150 %, of the standard drug and the mixtures were analysed by the 
proposed method. The experiment was performed in triplicate. The 
% recovery of each sample and % RSD was calculated at each 
concentration level. 
Limit of detection and limit of quantitation 
The limit of detection (LOD) is defined as the lowest concentration 
of an analyte that can be detected, but not necessarily quantified as 
an exact value.
in phosphate 
buffer of pH 7.4. The absorbance of each solution was scanned at 
270.5 nm using phosphate buffer as blank. Calibration curve was 
constructed by plotting concentration versus absorbance on x and y 
axis respectively. Linearity was determined by the regression 
equation. This experiment was repeated 3 times. 
Range is established by confirming that the analytical procedure 
provides an acceptable degree of linearity, accuracy and precision 
when applied to samples containing amounts of analyte within or at 
the extremes of the specified range of the analytical procedure. 
Precision 
The precision was determined at two levels as per ICH, Q2 (R1) 
guidelines i. e. Repeatability and intermediate precision [19].  
 The limit of quantitation (LOQ) is the lowest 
concentration of an analyte that can be quantitatively determined 
with acceptable precision and accuracy under the stated operational 
conditions of the method. 
LOD and LOQ of the drug were calculated using the following 
equations as per ICH guidelines. 
LOD = 3.3 × σ/S......... (1) 
LOQ = 10 × σ/S.......... (2) 
Where σ = the standard deviation of the response; S= the slope of the 
regression line. 
RESULTS AND DISCUSSION 
Wavelength of maximum absorption and preparation of 
calibration curve 
The wavelength of maximum absorption (ʎmax) was found to be 
270.5 nm in phosphate buffer (pH 7.4). The calibration curve was 
prepared in the concentration range of 2- 20 μg/ml. It observed that 
there was no change in the λmax of the drug in the concentration 
range 2- 20 μg/ml (Fig. 2).  
 
 
Fig. 2: Overlay spectra of donepezil in Phosphate buffer (pH 7.4) 
 
Method validation 
Linearity and range 
The absorbance of the drug solutions (2-20 μg/ml) was determined 
at 270.5 nm by UV spectrophotometer (UV -1800, Shimadzu 
Corporation, Kyoto, Japan). The mean absorbance range (n=3) was 
found to be 0.088-0.67 with RSD values below 2 % (Table 1). The 
calibration curve obtained was evaluated by its correlation 
coefficient (Fig. 3). The absorbance of the samples in the 
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concentration range of 2.0 -20 µg/ml was linear with a correlation 
coefficient (R2
The standard addition technique was carried out by adding 
excipients (in the likely range to be used) to be used in the 
formulation development with the addition of drug at 4 (50 %), 8 
(100 %) and 12 (150 %) μg/ml concentrations in sample solution of 
8 μg/ml.  ) 0.999.  
Precision 
The precision of the proposed method was assessed by analyzing 
donepezil in three different concentration levels as 6, 12 and 18 
μg/ml in triplicate. Results of repeatability (intraday precision) and 
intermediate (interday) precision were expressed in the terms of % 
RSD.  
The intraday and interday precision study of the developed method 
confirmed adequate sample stability and method reliability where 
all RSDs were below 2% (Table 2). 
Accuracy as recovery studies  
 
Fig. 3: Calibration curve of donepezil in phosphate buffer (pH 7.4)
 
Table 1: Calibration curve data for donepezil in phosphate buffer (pH 7.4) 
Concentration (µg/ml) Mean absorbance at 270.5 nm± SD (n = 3) Regressed absorbance Equation of Line 
2 0.088±0.004 0.081 1. Equation of Line 
y=0.0329x + 0.0154 
2. Correlation coefficient 
R² = 0.999 
3. Slope 
m = 0.0329 
4. Intercept 
c = 0.0154 
 
4 0.144±0.004 0.147 
6 0.214±0.004 0.213 
8 0.270±0.005 0.279 
10 0.342±0.005 0.344 
12 0.412±0.005 0.41 
14 0.477±0.006 0.476 
16 0.533±0.005 0.542 
18 0.620±0.030 0.608 
20 0.670±0.009 0.673 
 
Table 2: Precision of proposed method 
Concentration 
(μg /ml) 
Intraday precision (repeatability) Interday (intermediate) precision 
Mean absorbance 
at 270.5 nm ± SD (n=3) 
RSD 
(%) 
Day Mean absorbance at 270.5 nm ± SD (n=3) RSD 
(%) 
6 0.214±0.004 1.866 1 0.215±0.004 1.86 
2 0.211±0.002 0.95 
3 0.219±0.005 1.37 
12 0.412± 0.005 1.215 1 0.428±0.004 0.93 
2 0.414±0.006 1.44 
3 0. 423±0.007 1.65 
18 0.62±0.003 0.484 1 0.623±0.005 0.80 
2 0.634±0.003 0.47 
3 0.630±0.001 0.16 
 










Total including spiked sample 
(μg /ml) 
Spiked sample determined (μg/ml) ±  
SD (n = 3)  
50 8 12 11.83±0.21 98.50 1.77 
100 8 16 I5.94±0.29 99.63 1.82 
150 8 20 19.56±0.21 97.80 1.07 
 
Table 4: UV spectrophotometric parameters of donepezil 
S. No. Parameters Results 
1. Absorption maxima (nm) 270.5 
2. Linearity range (μg/ml) 2-20 
3. Regression equation  y = 0.0329x + 0.0154 
4. Slope 0.0329 
5. Intercept 0.0154 
6. Correlation coefficient (R2 0.999 ) 
7. Recovery (%) 97.80-99.63 
8. LOD (μg/ml) 0.401 
9. LOQ (μg/ml) 1.22 
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The proposed method afforded recovery of 97.80-99.63 % after 
spiking the additional standard drug solution to the previously 
analysed test solution.  
The value of % recoveries and % RSDs are shown in table 3. The 
high % recoveries indicated no interference of excipients that are 
used to prepare formulations of donepezil i. e. solid lipid 
nanoparticles. 
Limit of detection (LOD) and limit of quantitation (LOQ) 
LOD and LOQ of this method were determined by the standard 
deviation method. The value of LOD and LOQ was found to be 
0.401and 1.22 μg/ml respectively. A summary of all results is given 
in table 4. 
CONCLUSION 
The results and the statistical parameters demonstrated that the 
proposed UV spectrophotometric method is simple, rapid, specific, 
accurate and precise. Therefore, this method can be used to 
determine donepezil quantitatively for routine analysis in 
pharmaceutical preparations without interference of commonly 
used excipients and related substances. It has been proved that the 
method is selective and linear between concentration range 2-20 
μg/ml. The value of LOD and LOQ was found to be 0.401and 1.22 
μg/ml respectively. 
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